Published by Josh White on 15th June 2020
(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported a slight widening of its post-tax loss in its final results on Monday, to £2.7m, from £2.6m in the prior year.
URL: http://www.digitallook.com/dl/news/story/30791549/...